F. Edmondson
Algemeen Adviseur bij ZAI LAB LIMITED
Vermogen: 433 991 $ op 30-04-2024
Actieve functies van F. Edmondson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ZAI LAB LIMITED | Algemeen Adviseur | 07-08-2020 | - |
| Bedrijfssecretaris | 27-06-2022 | - |
Loopbaan van F. Edmondson
Eerdere bekende functies van F. Edmondson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01-06-2014 | 01-08-2020 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Bedrijfssecretaris | - | - |
Opleiding van F. Edmondson
| Washington & Lee University | Undergraduate Degree |
| Widener University School of Law | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Kaaimaneilanden | 2 |
Operationeel
| Corporate Secretary | 2 |
| General Counsel | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ZAI LAB LIMITED | Health Technology |
| BIOGEN INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
- Beurs
- Insiders
- F. Edmondson
- Ervaring